Eli Lilly (LLY) Treasury Shares (2009 - 2026)

Eli Lilly has reported Treasury Shares for 18 years, with the latest figure at $3.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 5986.87% year-over-year to $3.0 billion; the trailing twelve-month figure through Mar 2026 stood at $3.0 billion (up 5986.87% YoY), and the FY2025 full-year result was $3.0 billion, changed 0.0% from the prior year.
• Treasury Shares for Q1 2026 stood at $3.0 billion, roughly flat from $3.0 billion in the prior quarter.
• The five-year high for Treasury Shares was $50.0 million in Q4 2024, with the low at -$2.5 million in Q3 2021.
• Historically, Treasury Shares has averaged $6.0 million across 5 years, with a median of $450000.0 in 2022.
• Annual changes were most pronounced in 2024 — Treasury Shares slumped 98.91% — and 2025, when it soared 9114.68%.
• Eli Lilly's Treasury Shares stood at $3.0 billion in 2022, then sank by 98.53% to $44.2 million in 2023, then jumped by 6716.74% to $3.0 billion in 2024, then changed by 0.0% to $3.0 billion in 2025, then changed by 0.0% to $3.0 billion in 2026.
• The last three Treasury Shares figures came in at $3.0 billion (Q1 2026), $3.0 billion (Q4 2025), and $3.0 billion (Q3 2025), per Business Quant data.